Events
Webinar: More than Tested, Cured – Meaningful Engagement of Participants in Hepatitis C Work
Webinar: More than Tested, Cured – Meaningful Engagement of Participants in Hepatitis C Work Please join the Atlanta Harm Reduction Coalition, the National Viral Hepatitis Roundtable, the People’s Harm Reduction Alliance, and the Urban Survivor’s Union for a webinar on November 14, 2017. The webinar will provide an update on Read more…
Community Resource
Hepatitis C: State of Medicaid Access
Hepatitis C: State of Medicaid Access is the culmination of work by the Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) and the National Viral Hepatitis Roundtable (NVHR) to definitively assess the state of access to DAAs for Medicaid enrollees across America. Through a national report Read more…
Research
Perceived benefits of the hepatitis C peer educators: a qualitative investigation
https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-017-0192-8 New article from the Harm reduction journal about improving HCV treatment successes.
Community Resource
AASLD IDSA New Guidance
What’s New, Updates, and Changes to the Guidance This version of the guidance has been updated to reflect several important developments, including the recent approvals of glecaprevir/pibrentasvir and sofosbuvir/velpatasvir/voxilaprevir. Updated recommendations reflecting these approvals are provided throughout the guidance. In addition to updates to all the sections, the following new Read more…
Treatment
New Hep C Drugs
HCVAdvocate.org posted news about another cheaper Hep C drug. Hopefully the market will continue to compete the prices down! Learn more about the FDA drug pipline at http://hcvadvocate.org/treatment/drug-pipeline/#FDA Mavyret